UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000006159
Receipt number R000007074
Scientific Title Phase II trial of Trastuzumab in combination with Abraxane for patients with HER2-positive metastatic breast cancer
Date of disclosure of the study information 2011/08/15
Last modified on 2018/08/17 09:25:29

No. Disposal Last modified on Item of update
1 Insert 2011/08/12 12:16:04
2 Update 2018/01/05 12:21:47 Recruitment status
Anticipated trial start date
3 Update 2018/08/17 09:25:29 Last follow-up date
Date of closure to data entry